Vol. 20 No. 1 (2022): Blood Transfusion - 1 2022 (January-February)
Original article
-
Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in France
-
Alternative hepatitis B virus DNA confirmatory algorithm identified occult hepatitis B virus infection in Chinese blood donors with non-discriminatory nucleic acid testing
-
A clinical effect of disease-modifying treatment on alloimmunisation in transfused patients with myelodysplastic syndromes: data from a population-based study
-
Red cell proteasome modulation by storage, redox metabolism and transfusion
-
Red blood cell transfusions in preterm newborns and neurodevelopmental outcomes at 2 and 5 years of age
-
Investigating the association between blood transfusion and clinical outcomes in patients with acute coronary syndromes: a data linkage approach to patient blood management
-
Molecular characterization of rare D--/D-- variants in individuals of Indian origin
-
Promoting physical activity in people with haemophilia: the MEMO (Movement for persons with haEMOphilia) expert consensus project
Announcements
Winter Closure
The Editorial Office will be closed from December 31 to January 7, 2026.
Season’s greetings to all our readers, authors, and reviewers.
Read moreSIMTI 2026
46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)
Read moreSETS 2026
35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).Madrid, 4-6 June 2026.
Read moreEditorial Office Closure Notice
Please note that the BT Editorial Office will be closed until August 26, 2026.
During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.
Thank you for your understanding.
Best regards,
BT Editorial Office
Read more
Impact Factor 2025
We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.
Read more